Fritz H. Schröder
Researcher Next ID · RN-033777
Researcher · Medicine
Rotterdam, Netherlands
- Works count
- 774
- Citation count
- 41,705
- H-index
- 98
- i10-index
- 415
Research interests
Publications
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.02.009
Prostate cancer
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(14)61947-4
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60525-0
Prevention and early detection of prostate cancer
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70211-6
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies
European Urology · 2014 · https://doi.org/10.1016/j.eururo.2014.03.002
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.11.005
Quality-of-Life Effects of Prostate-Specific Antigen Screening
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1201637
Prostate-Cancer Mortality at 11 Years of Follow-up
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1113135
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
European Urology · 2011 · https://doi.org/10.1016/j.eururo.2011.03.055
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.24.1968
Screening and Prostate-Cancer Mortality in a Randomized European Study
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0810084
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
European Urology · 2009 · https://doi.org/10.1016/j.eururo.2009.07.018
Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies
Annals of Internal Medicine · 2008 · https://doi.org/10.7326/0003-4819-149-7-200810070-00006
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
British Journal of Urology · 2008 · https://doi.org/10.1111/j.1464-410x.2008.08183.x
Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
European Urology · 2008 · https://doi.org/10.1016/j.eururo.2008.11.011
Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
European Urology · 2008 · https://doi.org/10.1016/j.eururo.2008.09.052
Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients
Urology · 2005 · https://doi.org/10.1016/j.urology.2005.06.108
The TNM classification of prostate cancer
The Prostate · 1992 · https://doi.org/10.1002/pros.2990210521
Current projects
No projects listed.